Public health agencies worldwide have identified antibiotic resistance of disease-causing bacteria as one of humanity’s most critical challenges. However, scientists haven’t discovered a new class of antibiotics in more than 30 years. Now, researchers reporting in ACS Infectious Diseaseshave uncovered the hidden antibiotic potential of a non-psychoactive cannabis compound called cannabigerol (CBG), which helped control methicillin-resistant Staphylococcus aureus (MRSA) infections in mice.
For centuries, cannabis plants have been used in folk medicine. Today, scientists are only beginning to investigate whether different cannabis compounds could be used to treat a variety of diseases. Early studies have shown that some cannabinoids can slow the growth of gram-positive bacteria, such as S. aureus, but not gram-negative bacteria, such as E. coli. Eric Brown and colleagues wanted to test the antibacterial properties of several cannabinoids against both MRSA and gram-negative bacteria.
they found that if they gave CBG with another drug that pokes holes in this outer membrane, CBG could reach the inner membrane and kill gram-negative bacteria.
Read more at: https://neurosciencenews.com/cannabis-antibiotic-15791/